Index Option Calls
  • Home
  • Latest News
  • Email Whitelisting
  • Privacy Policy
  • Home
  • Latest News
  • Email Whitelisting
  • Privacy Policy
No Result
View All Result
Index Option Calls
No Result
View All Result
Home Latest News

Pfizer and BioNTech investigate Covid variant, as J&J tests vaccine against mutated virus

by
November 26, 2021
in Latest News
0
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

RELATED POSTS

FCC denies SpaceX bid for nearly $1 billion in rural broadband subsidies for Starlink

The easing of inflation pressures is giving the economy some breathing room, for now

A vial of Pfizer-BioNTech Covid-19 vaccine.

Getty Images

Pfizer and BioNTech are investigating the new, heavily mutated variant of the virus that causes Covid-19, the companies said Friday morning.

“We understand the concern of experts and have immediately initiated investigations on variant B.1.1.529,” the companies said.

Pfizer and BioNTech said they expect more data from lab tests in two weeks at the latest.

“These data will provide more information about whether B.1.1.529 could be an escape variant that may require an adjustment of our vaccine if the variant spreads globally,” the companies said.

Pfizer and BioNTech said they can adapt their mRNA vaccine within six weeks and start shipping batches within 100 days if an escape variant is identified.

Johnson & Johnson on Friday said they were already testing their vaccine against the new variant.

“We are closely monitoring newly emerging COVID-19 virus strains with variations in the SARS-CoV-2 spike protein and are already testing the effectiveness of our vaccine against the new and rapidly spreading variant first detected in southern Africa,” J&J said.

The variant, which emerged in South Africa, has about 50 mutations, more than 30 of which are on the spike protein that allows the virus to bind to human cells. The spread of the new variant is still in its early stages, and it’s not yet clear how severe an infection would be to a vaccinated person.

Several European and Asian nations have suspended flights from southern Africa in response to the variant. The United Kingdom suspended flights on Thursday from six countries in the region, and the European Commission – the European Union’s executive body – told all 27 member states to halt travel from southern Africa.

White House chief medical advisor Dr. Anthony Fauci on Friday said the U.S. is working with South African scientists to obtain the molecular makeup of the variant so lab tests can be conducted. Those tests would help determine whether or not the variant can evade antibody protection provided by the vaccines.

Fauci said that data would help determine whether or not the U.S. should implement similar travel restrictions.

The strength of Pfizer-BioNTech’s two-dose vaccine against infection has declined over time, although it’s still highly effective at preventing hospitalization and death. A study published in journal Science this month found that the vaccine’s efficacy declined from 86% to 43% from February to October.

The U.S. Centers for Disease Control and Prevention authorized booster shots of Pfizer-BioNTech’s vaccine for all adults last Friday. The booster dose was 95% effective at preventing symptomatic infection in people who had no evidence of prior infection in a clinical trial of 10,000 participants ages 16 and older.

ShareTweetPin

Related Posts

FCC denies SpaceX bid for nearly $1 billion in rural broadband subsidies for Starlink

by
August 10, 2022
0

A Starlink satellite terminal, also known as a dish, setup in front of an RV. SpaceX The Federal Communications Commission...

The easing of inflation pressures is giving the economy some breathing room, for now

by
August 10, 2022
0

A shopping cart is seen in a supermarket as inflation affected consumer prices in Manhattan, New York City, U.S., June...

Homebuyers Hit Brakes in July, Sellers Hold Back

by
August 10, 2022
0

by Calculated Risk on 8/10/2022 01:15:00 PM Today, in the Calculated Risk Real Estate Newsletter: Homebuyers Hit Brakes in July,...

U.S. charges Iranian military operative in plot to assassinate former Trump advisor John Bolton

by
August 10, 2022
0

National Security Advisor John Bolton answers questions from reporters as he announces that the U.S. will withdraw from a treaty...

Stocks making the biggest moves midday: Coinbase, Roblox, Wendy’s and more

by
August 10, 2022
0

Check out the companies making headlines in midday trading. Coinbase reported a 27% decline in revenues in the first quarter...

Next Post

Suze Orman's 5 moves to keep you out of the poorhouse in retirement

Warren Buffett recently sold these top dividend stocks, but he could be dead wrong about them — here's why they're still worth buying

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

email

Get the daily email about stock.

Please Enter Your Email Address:

By opting in you agree to our Privacy Policy. You also agree to receive emails from us and our affiliates. Remember that you can opt-out any time, we hate spam too!

MOST VIEWED

  • A Couple Stored IRA Gold at Home. They Owe the IRS More Than $300,000.

    0 shares
    Share 0 Tweet 0
  • A California Couple Spent Eight Years Building Their Dream Retirement Home in Costa Rica

    0 shares
    Share 0 Tweet 0
  • Goldman Sachs says buy these stocks to play Web 3.0 and the metaverse

    0 shares
    Share 0 Tweet 0
  • Goldman Sachs picks new stocks to buy — and says these 5 have over 100% upside

    0 shares
    Share 0 Tweet 0
  • In his final warning, this stock trading wizard — who made big money in bear markets and crashes — called this market a bubble like no other

    0 shares
    Share 0 Tweet 0
  • Home
  • Latest News
  • Email Whitelisting
  • Privacy Policy
All rights reserved by www.indexoptioncalls.com
No Result
View All Result
  • Home
  • Latest News
  • Email Whitelisting
  • Privacy Policy

All rights reserved by www.indexoptioncalls.com